M1 Kliniken AG

M12

Equity

ISIN DE000A0STSQ8 / Valor 29694419

Xetra (2024-11-20)

EUR 17.20-1.99%

M1 Kliniken AG
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

M1 Kliniken AG is a German-based company specializing in the provision of health services and medical treatments, particularly in the field of aesthetic medicine.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

In the first quarter of 2024, M1 Kliniken AG reported a 9.6% increase in consolidated sales, rising from EUR 76.8 million to EUR 84.7 million. This growth was primarily driven by the company's core Beauty segment, which continues to expand its market position worldwide.

Operating Earnings

M1 Kliniken AG saw a significant increase in operating earnings before interest and taxes (EBIT) in Q1 2024. The Group's EBIT rose by 70%, from EUR 4.0 million to EUR 6.8 million, resulting in an EBIT margin increase from 5.3% to 8.1%.

Beauty Segment Performance

The Beauty segment of M1 Kliniken AG showed particularly strong performance in Q1 2024. Sales in this segment increased by 18.2%, from EUR 20.9 million to EUR 24.7 million, while EBIT surged by 50%, from EUR 3.6 million to EUR 5.4 million. The EBIT margin for this segment improved from 17.3% to 21.9%.

Trading Segment Results

In the trading segment, M1 Kliniken AG also reported positive results for Q1 2024. Sales increased from EUR 55.9 million to EUR 60.0 million, and segment EBIT improved from EUR 0.4 million to EUR 1.4 million, reflecting the company's strong operational performance.

Future Outlook

M1 Kliniken AG is optimistic about its future growth, focusing on expanding its "M1 Med Beauty" network. The company aims to operate 150 to 200 specialist medical centers for aesthetic medicine by the end of 2029, with projected revenue of EUR 200 to 300 million and an EBIT margin of at least 20%. Additionally, M1 is considering strategic options for its trading segment to enhance shareholder value.

Summarized from source with an LLMView Source

Key figures

91.1%1Y

130%3Y

22.4%5Y

Performance

52.0%1Y

50.1%3Y

50.0%5Y

Volatility